253 related articles for article (PubMed ID: 8880865)
1. Neurofibromatosis and associated tumour suppressor genes.
Zwarthoff EC
Pathol Res Pract; 1996 Jul; 192(7):647-57. PubMed ID: 8880865
[TBL] [Abstract][Full Text] [Related]
2. The genetic and molecular pathogenesis of NF1 and NF2.
Yohay KH
Semin Pediatr Neurol; 2006 Mar; 13(1):21-6. PubMed ID: 16818172
[TBL] [Abstract][Full Text] [Related]
3. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
4. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
Kley N; Seizinger BR
Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520
[TBL] [Abstract][Full Text] [Related]
5. Mouse models of neurofibromatosis 1 and 2.
Gutmann DH; Giovannini M
Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543
[TBL] [Abstract][Full Text] [Related]
6. Advances in the treatment of neurofibromatosis-associated tumours.
Lin AL; Gutmann DH
Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
[TBL] [Abstract][Full Text] [Related]
7. New insights into the neurofibromatoses.
Gutmann DH
Curr Opin Neurol; 1994 Apr; 7(2):166-71. PubMed ID: 8019663
[TBL] [Abstract][Full Text] [Related]
8. [Neurofibromatosis].
Wolkenstein P; Decq P
Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
[TBL] [Abstract][Full Text] [Related]
9. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
11. [Molecular-genetic aspects of neurofibromatosis].
Hulsebos TJ
Ned Tijdschr Geneeskd; 1997 Mar; 141(13):620-3. PubMed ID: 9190537
[TBL] [Abstract][Full Text] [Related]
12. The neurofibromatoses: when less is more.
Gutmann DH
Hum Mol Genet; 2001 Apr; 10(7):747-55. PubMed ID: 11257108
[TBL] [Abstract][Full Text] [Related]
13. Tumour suppressor genes, immunology and local manifestations of neurofibromatosis phenotypes.
Gerosa PL; Spinelli M; Iannarelli S; Giussani G; Canepari C; Fontana A; Vai C; Bizzozero L
Panminerva Med; 1996 Sep; 38(3):157-63. PubMed ID: 9009679
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenesis in neurofibromatosis: new insights and potential therapies.
Reed N; Gutmann DH
Trends Mol Med; 2001 Apr; 7(4):157-62. PubMed ID: 11286939
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis. Nosological considerations.
Badiu C; Stefanache F
Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):39-44. PubMed ID: 12089989
[TBL] [Abstract][Full Text] [Related]
16. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis type 1: Fundamental insights into cell signalling and cancer.
Rad E; Tee AR
Semin Cell Dev Biol; 2016 Apr; 52():39-46. PubMed ID: 26860753
[TBL] [Abstract][Full Text] [Related]
18. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
[TBL] [Abstract][Full Text] [Related]
19. The tumour suppressor protein NF2/merlin: the puzzle continues.
Hovens CM; Kaye AH
J Clin Neurosci; 2001 Jan; 8(1):4-7. PubMed ID: 11148074
[TBL] [Abstract][Full Text] [Related]
20. [A new tumor suppressor gene responsible for type 2 neurofibromatosis is inactivated in neurinoma and meningioma].
Sanson M
Rev Neurol (Paris); 1996 Jan; 152(1):1-10. PubMed ID: 8729390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
